Compare ARMP & TORO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ARMP | TORO |
|---|---|---|
| Founded | N/A | 2022 |
| Country | United States | Cyprus |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Marine Transportation |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 156.4M | 174.5M |
| IPO Year | 1996 | 2022 |
| Metric | ARMP | TORO |
|---|---|---|
| Price | $4.75 | $5.05 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | ★ 166.3K | 23.3K |
| Earning Date | 05-07-2026 | 04-15-2026 |
| Dividend Yield | N/A | ★ 36.86% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.36 | $2.64 |
| 52 Week High | $14.98 | $8.50 |
| Indicator | ARMP | TORO |
|---|---|---|
| Relative Strength Index (RSI) | 39.95 | 52.22 |
| Support Level | $3.48 | $4.87 |
| Resistance Level | $7.67 | $5.25 |
| Average True Range (ATR) | 0.56 | 0.17 |
| MACD | 0.13 | 0.02 |
| Stochastic Oscillator | 53.96 | 62.70 |
Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.
Toro Corp is engaged in the acquisition, ownership, chartering, and operation of oceangoing tanker and LPG carrier vessels, providing seaborne transportation services for crude oil, refined petroleum products, and liquefied petroleum gas. The company operates through three segments: the Eco tanker segment, the Non-Eco tanker segment, and the LPG carrier segment. It generates the majority of its revenue from the LPG carrier segment.